BlackRock Inc. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 123 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$104,778,215
+2.7%
5,113,627
-0.4%
0.00%0.0%
Q2 2023$102,048,485
+9.0%
5,135,807
-6.1%
0.00%0.0%
Q1 2023$93,649,197
-14.4%
5,466,970
-2.2%
0.00%0.0%
Q4 2022$109,348,060
+52.5%
5,587,535
+24.3%
0.00%
+50.0%
Q3 2022$71,727,000
+30.1%
4,494,274
+12.2%
0.00%0.0%
Q2 2022$55,120,000
+4.3%
4,005,765
+20.2%
0.00%
+100.0%
Q1 2022$52,835,000
-27.5%
3,331,368
-0.2%
0.00%
-50.0%
Q4 2021$72,902,000
-24.2%
3,339,469
+3.8%
0.00%
-33.3%
Q3 2021$96,199,000
-31.5%
3,218,491
+1.5%
0.00%
-25.0%
Q2 2021$140,403,000
-2.9%
3,170,132
-2.7%
0.00%0.0%
Q1 2021$144,541,000
-11.2%
3,257,640
+9.7%
0.00%
-20.0%
Q4 2020$162,802,000
+147.7%
2,968,720
+3.3%
0.01%
+150.0%
Q3 2020$65,728,000
+5.3%
2,875,195
-3.6%
0.00%0.0%
Q2 2020$62,432,000
+65.4%
2,982,896
+10.2%
0.00%0.0%
Q1 2020$37,748,000
-37.1%
2,705,952
+2.6%
0.00%0.0%
Q4 2019$60,001,000
+96.7%
2,636,276
+0.7%
0.00%
+100.0%
Q3 2019$30,501,000
-20.7%
2,618,040
+2.1%
0.00%
-50.0%
Q2 2019$38,455,000
+3.6%
2,563,600
+21.1%
0.00%0.0%
Q1 2019$37,121,000
+29.2%
2,116,343
+9.2%
0.00%
+100.0%
Q4 2018$28,730,000
-20.5%
1,938,560
+32.0%
0.00%
-50.0%
Q3 2018$36,146,000
+41.0%
1,468,109
+12.4%
0.00%
+100.0%
Q2 2018$25,635,000
+1535.9%
1,305,876
+1462.8%
0.00%
Q1 2018$1,567,00083,5620.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders